GlassScriptPhysician profile
Teri O Dyess
NPI 1235201302
$8,849.51
in general payments reported to CMS, 2019-2025
30 companies · $1,123 in 2025
The $1,123 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $989 · 2020: $985 · 2021: $1,556 · 2022: $875 · 2023: $1,219 · 2024: $2,101 · 2025: $1,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,443.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,437.90 | 2021-2025 | Watchman Access System, Watchman |
| Astrazeneca Pharmaceuticals LP | $1,066.25 | 2019-2024 | Andexxa, Farxiga |
| Pfizer INC. | $1,059.02 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $902.07 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $583.06 | 2021-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $465.45 | 2019-2025 | |
| Amgen INC. | $436.65 | 2019-2025 | Evenity, Prolia |
| Novo Nordisk INC | $334.07 | 2023-2024 | Wegovy |
| Inari Medical, INC. | $305.07 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Gilead Sciences, INC. | $290.00 | 2021 | |
| Alexion Pharmaceuticals, INC. | $283.77 | 2022-2025 | Ultomiris |
| Abiomed | $242.79 | 2024-2025 | Impella |
| Abbvie INC. | $224.22 | 2021-2025 | Teflaro |
| E.R. Squibb & Sons, L.L.C. | $214.75 | 2019-2024 | Eliquis |
| Merck Sharp & Dohme LLC | $206.80 | 2020-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $156.28 | 2019-2021 | |
| Medtronic, INC. | $135.66 | 2023-2024 | Linq II |
| Phathom Pharmaceuticals, INC. | $129.41 | 2025 | Voquezna |
| Lilly USA, LLC | $106.79 | 2024 | Zepbound |
| Enterra Medical, INC. | $67.04 | 2023-2025 | |
| Mylan Specialty L.P. | $33.75 | 2019 | |
| Mallinckrodt Hospital Products INC. | $32.36 | 2024 | Terlivaz |
| Baxter Healthcare | $29.25 | 2023 | Hillrom - Life 2000 Ventilation System |
| Allergan, INC. | $23.50 | 2019-2020 | |
| Abbott Laboratories | $15.77 | 2025 | Freestyle Libre 3 |
| Sensible Medical Innovations INC | $14.77 | 2025 | Reds System |
| Genentech USA, INC. | $14.70 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $13.61 | 2023 | Inpefa |
| Medtronic Minimed, INC. | $12.73 | 2020 | |
| Avanir Pharmaceuticals, INC. | $12.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Teri Dyess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.